Acknowledgement
Supported by : BMS/Pfizer Pharmaceuticals Korea Ltd.
References
- Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005;20(1):26-30. https://doi.org/10.3346/jkms.2005.20.1.26
- Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol 2010;56(11):827-37. https://doi.org/10.1016/j.jacc.2010.05.028
- Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285(18):2370-5. https://doi.org/10.1001/jama.285.18.2370
- Diringer MN, Edwards DF, Mattson DT, Akins PT, Sheedy CW, Hsu CY, et al. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 1999;30(4):724-8. https://doi.org/10.1161/01.STR.30.4.724
- Dulli DA, Stanko H, Levine RL. Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 2003;22(2):118-23. https://doi.org/10.1159/000068743
- Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, et al. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336(7640):376-9. https://doi.org/10.1136/bmj.39456.688333.BE
- January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64(21):e1-76. https://doi.org/10.1016/j.jacc.2014.03.022
- Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123(7):638-645.e4. https://doi.org/10.1016/j.amjmed.2009.11.025
- Lip GY, Agnelli G, Thach AA, Knight E, Rost D, Tangelder MJ. Oral anticoagulation in atrial fibrillation: A pan-European patient survey. Eur J Intern Med 2007;18(3):202-8. https://doi.org/10.1016/j.ejim.2006.11.005
- Shin HW, Kim YN, Bae HJ, Lee HM, Cho HO, Cho YK, et al. Trends in oral anticoagulation therapy among Korean patients with atrial fibrillation: the Korean atrial fibrillation investigation. Korean Circ J 2012;42(2):113-7. https://doi.org/10.4070/kcj.2012.42.2.113
- Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, et al. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 2009;114(5):952-6. https://doi.org/10.1182/blood-2009-02-207928
- Reynolds MR, Shah J, Essebag V, Olshansky B, Friedman PA, Hadjis T, et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 2006;97(4):538-43. https://doi.org/10.1016/j.amjcard.2005.09.086
- NCSS. 2008. NCSS, LLC. https://www.ncss.com/. Updated 2012. Accessed December 10, 2012.
- Fleiss JL, Levin B, Paik MC. An introduction to applied probability. In: Shewart WA, Wilks SS, editors. Statistical Methods for Rates and Proportions. Hoboken, NJ: John Wiley & Sons, Inc.; 2004, 17-49.
- Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17(8):857-72. https://doi.org/10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
- Admassie E, Chalmers L, Bereznicki LR. Changes in oral anticoagulant prescribing for stroke prevention in patients with atrial fibrillation. Am J Cardiol 2017;120(7):1133-8. https://doi.org/10.1016/j.amjcard.2017.06.055
- Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, et al. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry. PLoS One 2016;11(10):e0164076. https://doi.org/10.1371/journal.pone.0164076
- Oh S, Goto S, Accetta G, Angchaisuksiri P, Camm AJ, Cools F, et al. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry. Int J Cardiol 2016;223:543-7. https://doi.org/10.1016/j.ijcard.2016.08.236
- Kim TH, Yang PS, Kim D, Yu HT, Uhm JS, Kim JY, et al. CHA2DS2-VASc score for identifying truly low-risk atrial fibrillation for stroke: a Korean nationwide cohort study. Stroke 2017;48(11):2984-90. https://doi.org/10.1161/STROKEAHA.117.018551
- Al-Jabi SW, Zyoud SH, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, et al. Relationship of treatment satisfaction to health-related quality of life: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Expect 2015;18(6):3336-48. https://doi.org/10.1111/hex.12324
- Sweileh WM, Ihbesheh MS, Jarar IS, Taha AS, Sawalha AF, Zyoud SH, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21(3):301-5. https://doi.org/10.1016/j.yebeh.2011.04.011
- Liberato AC, Rodrigues RC, Sao-Joao TM, Alexandre NM, Gallani MC. Satisfaction with medication in coronary disease treatment: psychometrics of the treatment satisfaction questionnaire for medication. Rev Lat Am Enfermagem 2016;24:e2705.
- Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One 2013;8(5):e63479. https://doi.org/10.1371/journal.pone.0063479
- Tulner LR, Van Campen JP, Kuper IM, Gijsen GJ, Koks CH, Mac Gillavry MR, et al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging 2010;27(1):39-50. https://doi.org/10.2165/11319540-000000000-00000
- Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160(1):41-6. https://doi.org/10.1001/archinte.160.1.41
- Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352(9135):1167-71. https://doi.org/10.1016/S0140-6736(98)01401-9
- Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract 1997;47(418):285-9.
- Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37(38):2893-962. https://doi.org/10.1093/eurheartj/ehw210
- January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130(23):2071-104. https://doi.org/10.1161/CIR.0000000000000040
- Bajorek BV, Ogle SJ, Duguid MJ, Shenfield GM, Krass I. Balancing risk versus benefit: the elderly patient's perspective on warfarin therapy. Pharm Pract (Granada) 2009;7(2):113-23.
- Wild D, Murray M, Donatti C. Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain. Expert Rev Pharmacoecon Outcomes Res 2009;9(5):467-74. https://doi.org/10.1586/erp.09.48
- Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur RE. Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract 2004;5(1):15. https://doi.org/10.1186/1471-2296-5-15
- De Caterina R, Bruggenjurgen B, Darius H, Kohler S, Lucerna M, Pecen L, et al. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: a PREFER in AF registry substudy. Arch Cardiovasc Dis 2018;111(2):74-84. https://doi.org/10.1016/j.acvd.2017.04.007
Cited by
- Patients’ and parents’ satisfaction with, and preference for, haemophilia A treatments: a cross‐sectional, multicentre, observational study vol.27, pp.4, 2018, https://doi.org/10.1111/hae.14304
- Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study vol.10, pp.17, 2018, https://doi.org/10.3390/jcm10173918